全球组织工程皮肤替代品的机会不断增长

Global Tissue-engineered Skin Substitute Growth Opportunities

出版日期: 2023年06月23日 | 出版商:

Frost & Sullivan | 英文 78 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

突破性技术和激烈竞争推动创新

烧伤、机动车事故和其他外伤以及糖尿病和静脉溃疡等慢性伤口的增加正在推动全球人造皮肤（组织工程皮肤替代品）市场的发展。此外，手术损伤、整形手术、整容手术和其他重建手术的增加预计将在预测期内（2023-2027年）推动市场增长。 2022 年，随着因 COVID-19 大流行而推迟的皮肤更换手术积压开始清理，市场出现收入大幅增长。

这份 Frost & Sullivan 研究报告分析了全球组织工程皮肤替代品市场，并介绍了最终用户的市场前景、用途类型的市场前景、治疗类型的市场前景、市场参与者的市场份额百分比等。我在这里。它还探讨了宏观经济因素、最新趋势、收益和预测、美国监管环境以及下一代组织工程皮肤替代技术和解决方案。研究期限为2022年至2027年，基准年为2022年。

它还确定了切实的市场增长机会，重点关注颠覆性创新、未开发的新市场以及美容旅游的激增。该研究排除了用于骨再生和修復的骨移植市场以及借助同种异体移植物製成的人造器官市场，例如用于心臟用途的同种异体移植主动脉瓣。

皮肤替代品的新兴应用领域，如整形手术、重建手术和术后伤口癒合预计将在预测期内增加。

预计将促进组织工程皮肤替代品市场的增长。合成组织工程皮肤替代品用于各种专业外科用途中的重建和修復目的，包括面部整形手术、真皮填充和根治治疗。其他用途包括整容、隆胸以及其他肢体和背部手术。此外，先进产品的推出，包括细胞和脱细胞皮肤喷雾产品，表明在临床皮肤病学中用于復杂伤口癒合的先进用途。整形外科医生也越来越多地使用皮肤替代品来治疗几种类型的皮肤缺陷，而不会最小化供体部位。

注射剂、微粒剂和喷雾剂等新型皮肤替代品正凭藉创新的製造技术进入组织工程皮肤替代品领域，使皮肤替代品能够快速发展并加速伤口癒合。顾客还想要更便宜、保质期更长的产品。这些产品还应该容易获得，使用无麻烦，并且在使用部位造成近乎零感染。颗粒（粉末）胎盘细胞外基质 (ECM)、喷雾皮肤替代品、3D 生物打印皮肤替代品和富血小板血浆 (PRP) 注射是本研究分析的一些下一代解决方案和技术。

该调查还涉及 CMS 于 2022 年 7 月宣布的皮肤替代品政策。该政策呼吁皮肤替代伤口护理管理产品更好地反映临床医生如何使用它们，并允许更加一致和透明的产品编码。生物皮肤替代品以比其他两种类型更高的采用率和偏好占据市场主导地位。儘管生物皮肤替代品可治疗中度至重度烧伤，但合成皮肤替代品领域预计将比生物皮肤替代品增长更快，这主要是由于生物材料技术不断进步。合成皮肤替代品可以控制支架成分。

分析范围
分割
主要竞争- 细胞皮肤替代品
主要竞争- 细胞皮肤替代品
市场进入者的组织工程皮肤替代品前景
最终用户对组织工程皮肤替代品的看法
组织工程皮肤替代品的用途前景
成长指标
增长促进因素
生长抑制因素
什么是组织工程皮肤替代品？
皮肤替代品按来源、成分和耐用性分类
按伤口类型定义组织工程皮肤替代品
根据伤口类型选择组织工程皮肤替代品
从传统伤口管理产品向现代伤口管理产品的转变
按植皮类型定义组织工程皮肤替代品
按细胞疗法类型定义组织工程皮肤替代品
按细胞疗法类型定义组织工程皮肤替代品
使用皮肤替代品 - 优点和缺点
预测假设
盈利和预测
按部门分類的盈利预测
按地区分類的收入预测
预测分析
竞争环境

组织工程皮肤替代品的监管状况 - 美国

Medicare 承保的伤口护理产品
Medicare 不承保的伤口护理产品
伤口治疗范围 - 概述
美国 FDA 对皮肤替代品的监管现状
皮肤替代品的兑换场景 - 合成替代品
2023年皮肤替代产品有哪些新变化？

市场进入者提供的产品

市场进入者的产品——细胞皮肤替代品
市场进入者的产品——细胞皮肤替代品
领先的伤口护理公司

下一代组织工程皮肤替代技术和解决方案

传统及新应用领域
用于伤口和烧伤的颗粒胎盘 ECM 设备 - InnovaMatrix(R) PD by ConvaTec
通过喷射皮肤细胞促进烧伤癒合
3D生物打印皮肤替代品
富血小板血浆（PRP）注射

充满增长机会的宇宙

增长机会一：颠覆性组织工程皮肤替代品创新
增长机会2：不断发展的美容旅游
增长机会3：政府对高级伤口癒合的支持和保险报销
增长机会4：瞄准亚太地区
增长机会5：基于传感器的皮肤贴片和电子皮肤

下一步

下一步
为什么是霜冻，为什么是现在？
附件清单
免责声明

简介目录

Product Code: K8FA-54

Breakthrough Technologies and Competitive Intensity Drive Innovation

Rising incidents of burn injuries, road accidents, and other trauma injuries, along with increasing cases of chronic wounds, such as diabetic ulcers and venous ulcers, are boosting the global tissue-engineered skin substitutes (TESS) market. Moreover, the increasing number of surgical injuries, plastic surgeries, cosmetic surgeries, and other reconstructive surgeries is expected to propel market growth during the forecast period (2023-2027). In 2022, the market witnessed a huge revenue spike as the backlog of skin substitute procedures postponed due to the COVID-19 pandemic started to be cleared.

This Frost & Sullivan study analyzes the global TESS market, including market landscape by end users, application types, therapy types, and market share percentage by market participants. It also examines macroeconomic factors, the latest trends, revenue forecasts, the US regulatory landscape, and next-generation TESS technologies and solutions. The study period is from 2022 to 2027, and the base year is 2022.

The study also highlights specific market growth opportunities, with a focus on disruptive innovation, new unaddressed markets, and the growing prevalence of cosmetic tourism. It excludes the bone grafts market for bone regeneration and repair and the market for artificial organs created with the help of allografts, such as allograft aortic valves in cardiac applications.

New application areas for skin substitutes, including plastic surgeries, reconstructive surgeries, and post-surgical wound healing, are expec

ted to increase during the forecast period and boost TESS market growth. A wide range of specialized surgical applications, such as facial plastic surgery, dermal fillers, and root therapy, use synthetic TESS for reconstructive and repair purposes. Other applications include face-lifts, breast augmentations, and limb or back additions. Moreover, the introduction of advanced products, including cellular and acellular skin spray products, suggests advanced usage in clinical dermatology for complex wound healing. Plastic surgeons are also increasingly using skin substitutes to treat several types of cutaneous defects without minimizing donor sites.

Novel skin substitute types in the form of injectables, particulates, and sprays are entering the TESS space along with innovative manufacturing technologies, enabling the faster development of skin substitutes and resulting in new features that accelerate wound healing. Customers are also demanding less-expensive products that offer longer shelf-life; these products must also be easily available and offer hassle-free application as well as low-to-zero infection at the application site. Particulate (powder form) placental extra-cellular matrix (ECM), spray-on skin substitutes, 3D bioprinted skin substitutes, and platelet-rich plasma (PRP) injections are some next-generation solutions and technologies the study analyzes.

The study also touches upon CMS policies for skin substitute products announced in July 2022, which state that skin substitutes will be called wound care management products to aptly mirror how clinicians use them, enabling more consistent and transparent product coding. Biological skin substitutes dominate the market as the adoption of and preference for these products is higher than the other 2 types. Though biosynthetic skin substitutes treat moderate-to-severe burns, the synthetic segment is expected to witness faster growth than biosynthetic skin substitutes, mainly due to the rising technological advancements in biomaterials. Synthetic skin substitutes demonstrate increased control over scaffold composition.

Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Tissue-engineered Skin Substitutes Market
Growth Opportunities Fuel the Growth Pipeline Engine™

Growth Opportunity Analysis

Scope of Analysis
Segmentation
Key Competitors-Acellular Skin Substitutes
Key Competitors-Cellular Skin Substitutes
TESS Landscape by Market Participants
TESS Landscape by End Users
TESS Landscape by Applications
Growth Metrics
Growth Drivers
Growth Restraints
Tissue-engineered Skin Substitutes-What are They?
Classification of Skin Substitutes by Origin, Components, and Durability
TESS Definitions by Wound Type
TESS Selection Based on Wound Type
Transition from Traditional to Advanced Wound Management Products
TESS Definitions by Skin Graft Types
TESS Definitions by Acellular Therapy Types
TESS Definitions by Cellular Therapy Types
Skin Substitute Usage-Pros and Cons
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Segment
Revenue Forecast by Region
Forecast Analysis
Competitive Environment

TESS Regulatory Landscape-The United States

Wound Care Supplies Medicare Covers
Wound Care Supplies Medicare Does Not Cover
Wound Care Coverage-An Overview
US FDA Regulatory Status for Skin Substitute Products
Skin Substitute Reimbursement Scenario-Synthetic Substitutes
What's New for Skin Substitute Products in 2023?

Market Participants' Offerings

Market Participants' Products-Acellular Skin Substitutes
Market Participants' Products-Cellular Skin Substitutes
Top Wound Care Companies to Watch

Next-generation TESS Technologies and Solutions

Traditional versus New Application Areas
Particulate Placental ECM Device for Wounds and Burns-ConvaTec's InnovaMatrix® PD
Spraying on Skin Cells to Accelerate Burn Healing
3D Bioprinted Skin Substitutes
Platelet-rich Plasma (PRP) Injections

Growth Opportunity Universe

Growth Opportunity 1: Disruptive TESS Innovation
Growth Opportunity 2: Growing Cosmetic Tourism
Growth Opportunity 3: Government Support and Reimbursements for Advanced Wound Healing
Growth Opportunity 4: Targeting the APAC Region
Growth Opportunity 5: Sensor-based Skin Patches and Electronic Skin